Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

Hodgkin Disease (Disease Or Phenotype)

Omim:236000

Nci:C26956

Msh:D006689

Mondo:MONDO:4604

Medcin:MEDCIN:31691

Mdr:MDR:10020255

Id:daa5a455-486d-53b0-9404-8e4bdb0c9aff

Icpc2icd10eng:MTHU047288

Icd10cm:C81.9

Efo:EFO:183

Doid:DOID:8567

Chv:CHV:6210

Results found

Linked to

	Label	Description
	Hydrocortisone indication Hodgkin Disease Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	triamcinolone indication Hodgkin Disease Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Bleomycin indication Hodgkin Disease Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	doxorubicin indication Hodgkin Disease Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Vincristine indication Hodgkin Disease Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	betamethasone indication Hodgkin Disease Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Acetic acid 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl ester indication Hodgkin Disease Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Hydrocortisone hemisuccinate indication Hodgkin Disease Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	prednisolone indication Hodgkin Disease Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Dacarbazine indication Hodgkin Disease Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Hydrocortisone indication Hodgkin Disease

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

triamcinolone indication Hodgkin Disease

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Bleomycin indication Hodgkin Disease

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

doxorubicin indication Hodgkin Disease

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Vincristine indication Hodgkin Disease

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

betamethasone indication Hodgkin Disease

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Acetic acid 2-((8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-10,13-dimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxo-ethyl ester indication Hodgkin Disease

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Hydrocortisone hemisuccinate indication Hodgkin Disease

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

prednisolone indication Hodgkin Disease

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

Knowledge Graph Assertion

Dacarbazine indication Hodgkin Disease

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.